Advisor Group Holdings, Inc. Vir Biotechnology, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,571 shares of VIR stock, worth $26,425. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,571

Previous 2,770 28.92%

Holding current value

$26,425

Previous $24,000 8.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.26 - $10.7 $5,815 - $8,570	801 Added 28.92%	3,571 $26,000
Q2 2024 Aug 13, 2024	SELL	$7.63 - $12.66 $862 - $1,430	-113 Reduced 3.92%	2,770 $24,000
Q1 2024 May 10, 2024	BUY	$8.6 - $11.9 $7,585 - $10,495	882 Added 44.08%	2,883 $29,000
Q4 2023 Feb 12, 2024	SELL	$7.76 - $10.29 $4,912 - $6,513	-633 Reduced 24.03%	2,001 $20,000
Q3 2023 Nov 13, 2023	SELL	$9.14 - $24.62 $1,334 - $3,594	-146 Reduced 5.25%	2,634 $24,000
Q2 2023 Aug 10, 2023	BUY	$23.2 - $27.29 $10,068 - $11,843	434 Added 18.5%	2,780 $68,000
Q1 2023 May 12, 2023	SELL	$22.26 - $30.85 $4,897 - $6,787	-220 Reduced 8.57%	2,346 $54,000
Q4 2022 Feb 10, 2023	SELL	$19.96 - $28.22 $23,792 - $33,638	-1,192 Reduced 31.72%	2,566 $64,000
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $45,650 - $77,750	2,500 Added 198.73%	3,758 $73,000
Q2 2022 Aug 10, 2022	SELL	$19.08 - $26.7 $130,659 - $182,841	-6,848 Reduced 84.48%	1,258 $32,000
Q1 2022 May 04, 2022	SELL	$21.19 - $40.01 $18,520 - $34,968	-874 Reduced 9.73%	8,106 $262,000
Q3 2021 Nov 05, 2021	BUY	$34.9 - $54.54 $54,060 - $84,482	1,549 Added 20.85%	8,980 $343,000
Q2 2021 Aug 02, 2021	BUY	$38.75 - $51.0 $852 - $1,122	22 Added 0.3%	7,431 $330,000
Q1 2021 May 13, 2021	SELL	$26.34 - $83.07 $318,740 - $1.01 Million	-12,101 Reduced 62.02%	7,409 $371,000
Q4 2020 Feb 10, 2021	BUY	$25.51 - $43.38 $458,210 - $779,191	17,962 Added 1160.34%	19,510 $523,000
Q3 2020 Nov 12, 2020	SELL	$28.28 - $53.6 $37,386 - $70,859	-1,322 Reduced 46.06%	1,548 $54,000
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $1,952 - $3,350	70 Added 2.5%	2,870 $117,000
Q1 2020 May 18, 2020	BUY	$12.04 - $60.2 $33,712 - $168,560	2,800 New	2,800 $96,000

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Vir Biotechnology, Inc. Transaction History